D
Daniel H. Teitelbaum
Researcher at University of Michigan
Publications - 295
Citations - 11878
Daniel H. Teitelbaum is an academic researcher from University of Michigan. The author has contributed to research in topics: Parenteral nutrition & Intraepithelial lymphocyte. The author has an hindex of 59, co-authored 295 publications receiving 10708 citations. Previous affiliations of Daniel H. Teitelbaum include Juntendo University & Nationwide Children's Hospital.
Papers
More filters
Journal ArticleDOI
Natural history of pediatric intestinal failure: initial report from the Pediatric Intestinal Failure Consortium.
Robert H. Squires,Christopher Duggan,Daniel H. Teitelbaum,Paul W. Wales,Jane Balint,Robert S. Venick,Sue Rhee,Debra L. Sudan,David F. Mercer,J. Andres Martinez,Beth A. Carter,Jason S. Soden,Simon Horslen,Jeffrey A. Rudolph,Samuel A. Kocoshis,Riccardo A. Superina,Sharon Lawlor,Tamara Haller,Marcia Kurs-Lasky,Steven H. Belle +19 more
TL;DR: The Pediatric Intestinal Failure Consortium performed a retrospective analysis of clinical and outcome data for a multicenter cohort of infants with IF to characterize the natural history of intestinal failure among 14 pediatric centers during the intestinal transplantation era.
Journal ArticleDOI
Pediatric short bowel syndrome: redefining predictors of success.
Ariel U. Spencer,Andreea Neaga,Brady T. West,Jared Safran,Pamela I. Brown,Imad F. Btaiche,Barbara Kuzma-O'Reilly,Daniel H. Teitelbaum +7 more
TL;DR: Age-adjusted small bowel length and ICV are the major predictors of weaning from PN in pediatric SBS, and cholestasis and age-adjustedSmall bowel length is the major predictor of mortality in children with SBS.
Journal ArticleDOI
Probiotics up-regulate MUC-2 mucin gene expression in a Caco-2 cell-culture model.
Aladdein Mattar,Daniel H. Teitelbaum,Robert A. Drongowski,F. Yongyi,C. M. Harmon,Arnold G. Coran +5 more
TL;DR: Enteral probiotics such as Lactobacillus casei GG may bind to specific receptor sites on the enterocyte and stimulate the up-regulation of MUC-2, resulting in increased inhibition of BT.
Journal ArticleDOI
One-stage transanal Soave pullthrough for Hirschsprung disease: a multicenter experience with 141 children.
Jacob C. Langer,Audrey C. Durrant,Luis De La Torre,Daniel H. Teitelbaum,Robert K. Minkes,Michael G. Caty,Barbara E. Wildhaber,S Jose Ortega,Shinjiro Hirose,Craig T. Albanese +9 more
TL;DR: This report represents the largest series of patients undergoing the 1-stage transanal Soave pullthrough, which is safe, permits early feeding, causes minimal pain, facilitates early discharge, and presents a low rate of complications.